W e read the article by Lee and colleagues with great interest [3] . Although the authors found that the combination of bone marrow aspirate concentrate (BMAC) and platelet-rich plasma (PRP) enhanced bone healing, it remains unclear which factor produces this effect because they were not evaluated separately. We do not know whether the combined treatment had synergistic effects on bone regeneration. The present study did not show, and therefore it is impossible to conclude, that the combined treatment was superior to that of either BMAC or PRP therapy alone.
We believe that the study design should have included four total groups instead of two. Along with the injection group and noninjection group in the original study, we would have included one group receiving PRP only and another group receiving BMAC only. The study results with four patient groups would have been more fruitful compared to only two study groups, which offered several limitations, which the authors acknowledge. Two recent studies [1, 2] revealed that solitary percutaneous autogenous bone marrow injection is effective in the treatment of nonunion and delayed union. Therefore, we can speculate that it is the BMAC, rather than PRP, that promotes bone healing in the present study. 
